Skip to content
GLP-1 Savers
Menu
Ranked #67 · Good Value

REMEVi review

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Est. first month

From $199/mo (starting dose, compounded)

Save ~85% vs brand-name
Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose. Confirm the current terms on the provider's own site before you commit.
Semaglutide
From $199/mo (starting dose, compounded)
Tirzepatide
From $269/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Compounded only

The Value Score card

REMEVi scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait64/100
Nationwide Availability96/100
Both Molecules92/100
Easy Cancellation95/100
Reputation87/100

Why it's a deal

  • The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
  • Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
  • LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
  • Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)

Read the fine print

  • Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
  • The specific compounding pharmacy is not named (described as 'NPI-verified')
  • A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements

The bottom line

Best for: Shoppers who want spanish-speaking patients wanting bilingual, LegitScript-certified compounded GLP-1. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Ranked #67 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to REMEVi, out of 394 others we track.

Shopping REMEVi against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs REMEVi, and every program that undercuts or outscores it is ranked on the REMEVi alternatives board.

More programs we track (24)

364 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from REMEVi's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to all deals